Showing results (111-120 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|July 9, 2011
When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populationsIris Manor, Shlomit Rozen, Zvi Zemishlani, et al.
Clinical Neuropharmacology|May 19, 2011
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington diseaseMouna Esmaeilzadeh, Johan Kullingsjö, Henrik Ullman, et al.
Clinical Neuropharmacology|May 19, 2011
Serotonin syndrome due to duloxetinePnar Gelener, Umit Gorgulu, Gulnihal Kutlu, et al.
Clinical Neuropharmacology|January 13, 2015
N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safetyMohammadali Nikoo, Hanieh Radnia, Mehdi Farokhnia, et al.
Clinical Neuropharmacology|January 13, 2015
Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapyAdam Wysokiński
Clinical Neuropharmacology|January 13, 2015
Quetiapine and clarithromycin-induced neuroleptic malignant syndromeChristos Christodoulou, Dimitris Margaritis, Gerasimos Makris, et al.
Clinical Neuropharmacology|January 29, 2016
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ERElizabeth W Triche, Jennifer A Ruiz, Kayla M Olson, et al.
Clinical Neuropharmacology|January 29, 2016
Development of Hiccup in Male Patients Hospitalized in a Psychiatric Ward: Is it Specifically Related to the Aripiprazole-Benzodiazepine Combination?Matteo Caloro, Daniela Pucci, Giuseppa Calabrò, et al.
Clinical Neuropharmacology|January 29, 2016
A Rare Case of Psychomotor Disturbances Linked to the Use of an Adulterated Dietary Supplement Containing SibutramineBarak Shapira, Lee Goldstein, Amikam Reshef, et al.
Clinical Neuropharmacology|January 13, 2016
Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary StudyAntonio Bruno, Gianluca Pandolfo, Clemente Cedro, et al.
Pageof 236